Astria Therapeutics Presents Additional Data Supporting STAR-0215 Profile as a Long-Acting Preventative Therapy for Hereditary Angioedema

Aluna Raises USD 15.3m in Series B Funding

ALK's regulatory filing for house dust mite allergy tablet accepted for review in China

First Patient Dosed in Adaptive Phage Therapeutics' PHAGE Clinical Trial Evaluating Phage Therapy in Cystic Fibrosis-related Respiratory Infection

Loreaux, Humphries Named to Bryn Pharma Board of Directors

AcuCort signs exclusive commercial agreement with Kamada

MediPrint Ophthalmics Has Initiated Its SIGHT-2 Phase 2b Clinical Study for Its Lead Asset

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma

DC4U and LUMC consortium receives grant to jointly develop Type I diabetes treatment

US FDA Accepts ARS Pharmaceuticals' NDA for neffy for the Treatment of Allergic Reactions (type I) including Anaphylaxis

Intravacc receives contract from US National Institute of Allergy and Infectious Diseases

First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate